TDACW Company Profile and Key Details

The stock is currently trading near its 52-week high $0.33 and $1.61. With a market capitalization of about $239.76 million, Translational Development Acquisition Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.11). Key stats such as the average daily volume over the past year has been around 57.95 thousand shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, Translational Development Acquisition Corp. operates in the Financial Services sector and the Shell Companies industry. Led by CEO Michael Hoffman, the company employs approximately 2 people and listed since June 16, 2025. Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations.

Translational Development Acquisition Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $4.57. This means the shares are trading below this model’s fair value.

Average 10-day trading volume of 2.50 thousand shares is below the 3-month average of 9.25 thousand, indicating normal recent market interest.

Our AI price prediction model suggests that Translational Development Acquisition Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Translational Development Acquisition Corp. trading at a premium to the broader market with a P/E of 42.27.

Translational Development Acquisition Corp. trades at a P/E ratio of 42.27, slightly above the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 1.23 suggesting the stock is closer to book value. The P/FCF stands at -315.78, also below market averages.